Author Archive

Paxlovid Black Box Warning: It Interacts With 32 Classes of Drugs

https://rumble.com/v1es6w5-paxlovid-is-one-of-the-most-toxic-drugs-we-have-dr.-richard-urso.html  Video Here (Approx. 2 Min)

Paxlovid ‘Is One of the Most Toxic Drugs We Have’: Dr. Richard Urso

Dr. Deborah Birx on CNN states:

“Right now the key is testing and Paxlovid.”

“What’s gonna save you now is Paxlovid.”

Birx, accused of falsifying data, is horribly wrong on both accounts.

COVID testing, much like Lyme testing is a complete and utter farce.

A centralized dictate now allows Pharmacists to diagnose, prescribe, and bill patients – by passing doctors entirely.

Dr. Richard Urso states that Paxlovid is one of the most toxic drugs on the market that interacts with 32 CLASSES of drugs.

The drug is also known to cause a “rebound effect,” that both Fauci and Biden suffered from.  Fauci’s rebound was worse than his first infection.

Yet, the same centralized health monopoly will deny Lyme/MSIDS patients life-saving antimicrobials.

For more on effective COVID treatments that have been censored and banned:

Pfizer and Valneva Move on to Lyme Vaccine

https://apnews.com/article/science-health-ticks-

Major test of first possible Lyme vaccine in 20 years begins

August 8, 2022
Robert Terwilliger, right, of Williamsburg, Pa., who is participating in a Lyme disease vaccine trial at the Altoona Center for Clinical Research, is injected with either the new vaccine or a placebo, by registered nurse Janae Roland, Friday, Aug. 5, 2022, in Duncansville, Pa. Lyme is a growing problem, with cases steadily rising and warming weather helping ticks expand their habitat. (AP Photo/Gary M. Baranec)

DUNCANSVILLE, Pa. (AP) — Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years — in hopes of better fighting the tick-borne threat.

Lyme is a growing problem, with cases rising and warming weather helping ticks expand their habitat. While a vaccine for dogs has long been available, the only Lyme vaccine for humans was pulled off the U.S. market in 2002 from lack of demand, leaving people to rely on bug spray and tick checks.

Now Pfizer and French biotech Valneva are aiming to avoid previous pitfalls in developing a new vaccine to protect both adults and kids as young as 5 from the most common Lyme strains on two continents.

(See link for article)

_________________

**Comment**

Here we go again…..

  • True to form, the only time ‘the powers that be’ bring up the fact Lyme/MSIDS is a growing problem is when there’s a vaccine in the pipeline.
  • This “vaccine” targets OspA, the same protein in Lymerix that caused Lyme-like symptoms in many that was supposedly pulled due to “lack of demand.”
  • The 36 hours for transmission is foolishly regurgitated as transmission can and often occurs much quicker, raising the question of whether or not there is even enough time for antibodies to do their supposed magic.
  • Please notice that Pfizer and Valneva are behind this.
    • French pharmaceutical company Valneva joined up with Pfizer (a company which has been fined over 3.5 billion for safety violations, false medical claims, corruption, bribery and has demanded countries put up sovereign assets, bank reserves, military bases and embassy buildings as collateral for expected lawsuits from COVID shots.  This article outlines the fraud and corruption and questions how Pfizer managed to rebrand itself as savior of humanity (one could ask the same question about Bill Gates). If you still trust these companies I have land in Siberia I’d like to sell you.
  • They aim to recruit 6,000 people, including kids as young as five, from endemic areas. Those who enroll will get three shots of either the vaccine or a placebo. It remains to be seen if it is truly a placebo – which should be an inert substance, or another vaccine, which they often do in trials to muddy the waters and make it impossible to truly determine safety.  A year later they will get a booster.
  • They consider this a seasonal vaccine and people will need to continue getting them.
  • They state Lymerix drew “unsubstantiated reports of joint-related side effects.”  I talk to these “unsubstantiated” patients regularly who are still suffering from the effects of Lymerix. Trust me when I say the damage is real, but don’t take my word for it, read about examples here and here.  Hopefully by now it’s become clear that those who suffer vaccine damage are gaslit just like Lyme/MSIDS patients.
    • The dirty little secret is LYMErix was given “permissive” recommendation by the CDC (the injection was only advised for those ‘at risk’, not the whole population). This designation allowed those suffering with adverse reactions to sue the manufacturer, which they did.  I assure you, no such designation will be given this new jab and you will be SOL if you are injured from it.
  • While this vaccine targets 6 Lyme strains, there are other strains out there, and this doesn’t touch coinfections which are often a part of the picture.  Please note the continued singular attention to Lyme with no regard to other infections ticks carry.  This one-microbe, one treatment, one vaccine paradigm is completely wrong but drives nearly all mainstream research.
  • The article mentions the University of Massachusetts work on a “vaccine alternative” – shots of pre-made Lyme-fighting antibodies.
    • Dr. Mark Klempner’s lucrative jabLyme PrEP, is now in Phase 1 trials. Please know the backstory on Klempner. He claims this new shot isn’t a “vaccine;” however, according to thisOspA is still in it, and this study states a wide range of neurological complications have been reported to VAERS after vaccination with OspA including cerebral ischemia, transient ischemic attacks, demyelinating events, optic neuritis, transverse myelitis and non-specific demyelination.
    • Here’s what Dr. Stricker has to say:

OspA:  Another Lyme OspA Vaccine Whitewash 

“The meta-analysis by Zhao and colleagues comes to the conclusion that “the OspA vaccine against Lyme disease is safe and its immunogenicity and efficacy have been verified.” The authors arrive at this sunny conclusion by excluding 99.6% of published articles that demonstrate potential problems with the OspA vaccine. Furthermore, the authors ignore peer-reviewed studies, FDA regulatory meetings and legal proceedings that point to major problems with OspA vaccine safety (1-3). This whitewash bodes ill for future Lyme vaccine candidates because it fosters disregard for vaccine safety among Lyme vaccine manufacturers and mistrust among potential Lyme vaccinees.” ~ Dr. Stricker

  • The article also mentions Yale’s work designing a vaccine that recognizes tick saliva — which in animal testing sparked a skin reaction that made it harder for ticks to hang on and feed.
    • John Aucott is “cloning a bunch of proteins in tick saliva” to replicate tick resistance.  He’s also an adviser to Tarsus Pharmaceuticals, a biopharmaceutical company which is authorized by the F.D.A. to develop an oral preventative in humans using lotilaner, the active ingredient in Credelio, a veterinary medication prescribed for dogs and cats to prevent fleas and ticks which is targeted to the parasite’s nervous system but supposedly doesn’t have any effect on mammals.
  • This is where the money is – vaccines and seasonal treatments people will purchase time and again.  Notice that nothing is ever said about an accurate test and effective treatments for suffering patients.  Many, including yours truly believe Lyme was pigeonholed by the two principal investigators of the previous Lyme vaccines to fit a simplistic one pathogen paradigm for vaccine development.  This is why they continue to deny chronic/persistent infection despite research to the contrary.

And speaking of money:

    • The FDA in July 2017 issued Valneva a fast-track designation that specifically allows for expedited review of “drugs to treat serious conditions and fill an unmet medical need.”
    • Valneva sold the rights to VLA15 to Pfizer for an upfront cost of $130 million in 2020, at which time the two companies announced a collaboration for the continued development and commercialization of the vaccine.
    • Under the terms of the two companies’ agreement, the first dose in the Phase 2 study triggered an additional $10 million payment from Pfizer to Valneva.
    • According to Fierce Biotech, a successful Phase 3 trial “could give Pfizer a clear run at a growing opportunity” and “offers Pfizer the chance to add a growth driver to its mammoth vaccine unit,” as the number of reported Lyme disease cases in the U.S. has increased threefold since the late 1990s.  Source
  • Mark Crispin Miller, a professor of media studies at New York University who has experienced the symptoms of Lyme disease, drew comparisons between the experimental Lyme disease vaccine and the COVID-19 vaccines.

“No doubt the CDC/FDA will bless this Lyme vaccine, regardless of its risks, just as they’ve pushed the COVID ‘vaccines’ for the last two years.

“And their support for this new vaccine is especially perverse, since the CDC et al. have long denied that ‘chronic Lyme’ exists, because its proper treatment would cost more than the insurance carriers want to pay.

“As one who has been battling Lyme for more than 10 years, and at enormous cost, I see no reason to put any trust at all in those authorities, whose long denial of the reality of this condition has done me, and countless others, grievous harm.” ~ Mark Crispin Miller

I couldn’t agree more.
And I’m with Lyme Advocate Carl Tuttle:  No Lyme Vaccine Until persistent infection is acknowledged and fully addressed.

Child With Lyme Diagnosed With Radiculopathy

https://danielcameronmd.com/child-with-lyme-disease-diagnosed-with-radiculopathy/

Child with Lyme disease diagnosed with radiculopathy

lyme-disease-radiculopathy

“Among the signs and the symptoms connected to the presence of neuropathic pain are allodynia (pain due to a stimulus that does not normally provoke pain), hyperalgesia (an increase in the perception of pain generated by a stimulus that causes pain), and paresthesia (a condition that determines the perception of anomalous sensations comparable to needle bites, tingling, itching, reduced, or even loss of sensitivity),” wrote Cavalli and colleagues in the International Journal of Immunopathology and Pharmacology. [1]

A 10-year-old boy presented with fatigue, posterior lower neck pain, and a low-grade fever of 100.8. “The soft tissues of the posterior neck and upper back were tender with allodynia,” wrote Baker and colleagues in the American Journal of Emergency Medicine.²

They added, the Magnetic Resonance Imaging (MRI) of the cervical spine showed “questionable” nerve root enhancement at levels C5-C6 and C6-C7 consistent with radiculitis. The child was discharged from the emergency room with a diagnosis of cervical radiculitis due to viral infection.

Two days later, the child was diagnosed with Lyme disease with a positive IgM and IgG western blot test. The patient’s symptoms resolved following treatment with oral doxycycline.

The authors pointed out that radiculoneuritis due to Lyme disease is not new. “In US children, meningitis and cranial nerve palsy are relatively common in neuroborreliosis, while radiculoneuritis is rare,” wrote the authors.²

They added, “Neuroborreliosis is easier to recognize when facial nerve palsy or meningitis are present with radiculitis since these are classically associated with Lyme.”

“Any patient with painful radiculitis and plausible exposure to potentially infected ticks should have Lyme testing,” the authors concluded.

CDC Caught Lying Yet Again About Association Between Heart Inflammation & mRNA Shots & Professor Shows a Relationship Between Excess Deaths & Shots

http://  Approx. 10 Min

Aug. 9, 2022

A FOIA request finally received a response from the CDC.  The CDC states for the period between April to October 2021:

“The National Center for Emerging Zoonotic Infectious Diseases performed a search of our records that failed to reveal any documents pertaining to your request.”

It goes onto say:

“….during the period specified, no abstractions were performed for myocarditis: an association between myocarditis and mRNA COVID-19 vaccination was not known at that time.  Likewise, we have no reports during that period.:

This is a blatant lie.

The first reports of myocarditis (14 cases) in the military were being tracked by the Pentagon (as well as Israeli authorities) back in April of 2021.  A month later in May, 2021 the CDC investigated heart inflammation in “vaccinated” teens and young adults. And yet again in June, 2021 there were another 800 reports in the VAERS system of heart inflammation after the gene therapy shots. CDC researchers stated the available data:

“suggests an association with immunization.”

In August, 2021, those same CDC researchers put together a presentation describing the issue of heart inflammation as “harm from vaccination.”

The Epoch Times then reached out to Barbara Loe Fischer, head of NVIC, who states:

“[The claim that the link wasn’t known] is provably false….Either the right hand does not know what the left hand is doing at the CDC or federal health officials are disseminating misinformation about what they knew about myocarditis following mRNA COVID vaccines and when they knew it.”

Perhaps to the publicity the inquiry was generating, the CDC then offered a correction email which states:

“Apparently the CDC needs to make a correction! [The agency is acknowledging that by June 2021, data began to indicate a link between the mRNA COVID-19 vaccines and heart inflammation, outlined that month in two presentations made to government vaccine advisory panels.] Additional data accumulated in subsequent months, ultimately leading to the conclusion that a causative association did indeed exist.  However, such a conclusion required time to accumulate and analyze data.”

While the CDC has issued a correction, albeit a late one and only done due to pressure, they still haven’t answered the FOIA request for the internal documents within the CDC regarding heart inflammation.

Wisconsin Senator Ron Johnson has also attempted to get this information with the same result.

“[The CDC’s response] raises even more questions about the agency’s honesty, transparency, and use, or lack thereof, of its safety surveillance systems, such as VAERS, to detect COVID-19 vaccine adverse events.  I have sent two letters to the CDC about the agency’s inability to find records demonstrating its use of the vaccine surveillance systems.  To date, the CDC has failed to respond to my letters.” ~ Senator Ron Johnson

Where are the documents?

Why is it so difficult to get information, which should be transparent and readily available for the public, from America’s top public health agency entrusted with monitoring adverse events from vaccinations that they are pushing and mandating?

Answer:  they are hopelessly and utterly corrupt and undeserving of our trust.

http://

Preprint From Thailand Shows 1 in 43 Teens Get Myocarditis After COVID Shot

Aug. 12, 2022

Kim Iversen & Dr. Peter McCullough

________________

http://

Professor Richard Ennos on the Increase in Sudden Deaths

“So Often We Are Told These Things Are Just A Coincidence.”

July 27, 2022

GBN News Mark Steyn interviews University of Edinburgh, Professor Richard Ennos, who explains the experiment they ran to determine the cause of the excess deaths.  At the beginning of 2022 we didn’t have excess deaths, but excess deaths began in Scotland about 10 weeks into 2022.  The deaths started in the older age groups first and then began in the younger age groups as well, exactly as they predicted  – that there is a relationship between the COVID shots and the excess deaths.

If that isn’t enough, Dr. Clare Craig (consultant pathologist in England who states the FDA should not have granted EUA of the shots for children) states:

“After Pfizer, Moderna, one in 500 had a serious adverse event. And after AstraZeneca is one in 142.”

After ‘coincidences’ are factored in, the approximated rate is between one in 500 and one in 5000.

She also gave written evidence on the many problems with data transparency and accountability regarding COVID.

New data from the Netherlands ALSO reveals a link between higher “vaccine” uptake and higher mortality.  Dutch researcher André Redetti compares mortality rate and vaccine uptake between municipalities in the Netherlands and finds no mortality-reducing effect from vaccination.

Instead he finds a statistically significant positive correlation between vaccine uptake and mortality.

The full analysis is not yet peer reviewed, but it is available on Researchgate(See link for article)

We’ve been told repeatedly that the mRNA “vaccines” are “safe and effective,” yet they don’t prevent transmission or infection, and they don’t prevent severe illness or death, and actually have negative efficacy with evidence of increased risk of myocarditis & pericarditis in the week following the injections and a positive correlation between “vaccine” uptake and increased mortality.

__________________

This news story shows that in Taiwan more died after the COVID Shot than from COVID.

This is not the first time this information was made public.  In fact over a year ago, one team published an engineering analysis to determine the current underreporting factor (URF) from the VAERS information and found the factor to be 41. When applied against the government data they found 173% more children died from the vaccine than from the illness.

Many scientists and health experts have warned that vaccinating children against COVID-19 is unnecessary and extremely risky.

http://  Approx. 9 Min

Unexpected 40% Increase in ‘All Cause Deaths’ in 2021

Feb. 2, 2022

KUSI presents Dr. Kelly Victory, Emergency Medicine & Disaster Specialist

In response to this bombshell, the DOD simply edited the military medical database to hide the COVID shot injuries.

If you are unfamiliar with the story on how the DOD “recalibrated” health surveillance data, see this article, as well as this article which states the Pentagon’s reaction only seems to be concerned with exonerating the “vaccine,” not fixing its own alleged health surveillance problem.

SUMMARY:

  • The DOD magically and suddenly discovered 5 years of “false data” only after attorney Renz came forth with shockingly dramatic increases in medical diagnoses among the military.
  • According to Horowitz, the DOD is only concerned with downplaying any potential culpability of the vaccine, not explaining how military health data could be so wrong.
  • This means the CDC was looking at data for months that showed insane safety signals and did nothing about it, and somehow nobody in HHS or the DOD all along thought the data was a “glitch.”
  • Horowitz further states that there is no way the “new” data could be updated so quickly.
  • Just take a look at the two graphs, the first of which shows the original data of total outpatient diagnoses before the Pentagon changed it:

For more:

US Insurance Claims Data Shows Explosive Growth of Lyme Disease

https://www.lymedisease.org/fair-health-lyme-insurance-data/

US insurance claims data shows explosive growth of Lyme disease

From 2007 to 2021, private insurance claim lines with Lyme disease diagnoses rose 357 percent in rural areas and 65 percent in urban areas.

[Editor’s note: “claim lines” are not the same as individual Lyme cases. A claim line is a request for insurance reimbursement. One Lyme patient may have several claim lines, for lab tests, x-rays, etc.]

These and other findings on this tick-borne, bacterial illness were captured in an infographic just released by FAIR Health. The national, independent organization used its database of over 36 billion privately billed healthcare claims to conduct its 15-year analysis of Lyme disease.

This analysis builds upon a previous FAIR Health infographic that studied 10 years of Lyme disease data. Click here for the infographic released today.

Rural and urban differences

The infographic reveals key differences in prevalence of Lyme disease when comparing rural and urban areas. From 2016 to 2021, claim lines with Lyme disease diagnoses increased 60 percent in rural areas and 19 percent in urban areas, with diagnoses peaking nationally in June and July of each year.

During these summer months, rural areas, on average, had a greater share of claim lines associated with Lyme disease diagnoses than urban areas. From November to April, however, claim lines with Lyme disease diagnoses occurred more often in urban than rural areas.

Geographic distribution

In 2017, the states with the greatest proportion of claim lines with Lyme disease diagnoses as a percentage of all diagnoses in the state, from highest to lowest, were New Jersey, Connecticut, North Carolina, Rhode Island and Vermont.

Given that Lyme disease has been historically associated with the Northeast and upper Midwest, the status of North Carolina as the state with the third highest percentage of Lyme disease claim lines in 2017 suggested marked expansion to a new region. By 2021, however, North Carolina had dropped from the list.

The top states in 2021, from highest to lowest, were New Jersey, Vermont, Maine, Rhode Island and Connecticut. Maine, which was not previously on the list of top five states for Lyme disease claim lines, assumed third place in 2021, suggesting a growing presence of the tick-borne illness in the state. Connecticut and Vermont switched places, with Vermont emerging as number two and Connecticut dropping to number five.

Long-term symptoms of Lyme disease

Although Lyme disease is treatable with antibiotics, some Lyme patients later develop conditions with long-term symptoms, such as fatigue, muscle and joint pain and cognitive issues. Such conditions have been linked to post-treatment Lyme disease syndrome, sometimes called chronic Lyme disease.

To identify later diagnoses associated with Lyme disease, FAIR Health examined a statistically significant cohort of individuals in its private insurance claims database from 2017 to 2021, comparing the prevalence of certain diagnoses among Lyme patients to all patients in the cohort.

The analysis found that diagnoses such as malaise and fatigue and soft-tissue-related issues were more common among Lyme patients than among the total patient population. Across all age groups, patients with Lyme disease were generally more likely to have these apparently associated diagnoses than all patients in the cohort.

FAIR Health President Robin Gelburd stated, “Lyme disease remains a growing public health concern. FAIR Health will continue to use its repository of claims data to provide actionable and relevant insights to healthcare stakeholders seeking to better understand the ongoing rise of Lyme disease cases.”

This is the third study FAIR Health has conducted on Lyme disease, the first appearing in an infographic released in 2017 and the second in a white paper published in 2019.

About FAIR Health

FAIR Health is a national, independent nonprofit organization. It possesses the nation’s largest collection of private healthcare claims data, which includes over 36 billion claim records and is growing at a rate of over 2 billion claim records a year.

SOURCE OF PRESS RELEASE:  fairhealth.org

______________

For more: